Sagimet Biosciences (SGMT) Current Deferred Tax Assets (2023 - 2026)

Sagimet Biosciences' Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $402000.0 for Q1 2026.

• In Q1 2026, Current Deferred Tax Assets fell 35.68% year-over-year to $402000.0; the TTM figure through Mar 2026 stood at $402000.0 (down 35.68% YoY), while the FY2025 annual figure was $282000.0, down 7.84% from the prior year.
• Current Deferred Tax Assets was $402000.0 for Q1 2026 at Sagimet Biosciences, up from $282000.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $2.6 million in Q2 2023 to a low of $247000.0 in Q3 2025.
• Historically, Current Deferred Tax Assets has averaged $638666.7 across 4 years, with a median of $323000.0 in 2023.
• The sharpest annual moves came in 2024 and 2026: Current Deferred Tax Assets slipped 5.26% in 2024, then tumbled 35.68% in 2026.
• A 4-year view of Current Deferred Tax Assets shows it stood at $323000.0 in 2023, then slipped by 5.26% to $306000.0 in 2024, then dropped by 7.84% to $282000.0 in 2025, then surged by 42.55% to $402000.0 in 2026.
• The last three Current Deferred Tax Assets figures came in at $402000.0 (Q1 2026), $282000.0 (Q4 2025), and $247000.0 (Q3 2025), per Business Quant data.